A recent study from the Centro Nacional de Investigaciones Cardiovasculares (CNIC) reveals a critical role for mitochondrial complex I in the activation of T lymphocytes by dendritic cells, which are vital for the immune response against viruses and tumors. Published in *Science Immunology*, the research shows that proper mitochondrial function is necessary for dendritic cells to convert viral or tumor-derived materials into effective immune signals. When mitochondrial complex I is dysfunctional, dendritic cells cannot adequately present antigens to T lymphocytes, leading to reduced immune activation. The study's co-first authors, Sofía C. Khouili and Elena Priego, highlight that correcting the chemical imbalance caused by complex I deficiency can restore dendritic cell function and enhance T cell responses. This discovery points to new avenues for developing improved vaccines and cancer immunotherapies by targeting mitochondrial activity in dendritic cells. The findings suggest that understanding and manipulating this metabolic checkpoint could significantly enhance the effectiveness of current immunotherapeutic strategies.